Enantiopure 3-(arylmethylidene)aminoxy-2-methylpropionic acids: synthesis and antiinflammatory properties

被引:7
作者
Balsamo, A
Bertini, S
Gervasi, G
Lapucci, A
Nencetti, S
Orlandini, E
Rapposelli, S
Rossello, A
Soldani, G
机构
[1] Univ Pisa, Fac Farm, Dipartimento Sci Farmaceut, I-56100 Pisa, Italy
[2] Univ Pisa, Fac Vet, Dipartimento Clin Vet, I-56100 Pisa, Italy
[3] Lab Baldacci SpA, I-56100 Pisa, Italy
关键词
antiinflammatory drug; NSAID; 3-aminoxy-2-methylpropionic acid;
D O I
10.1016/S0223-5234(01)01275-2
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Some optically active 3-(arylmethylidene)aminoxy- (3a-g, 4a-g) and fluorenylideneaminoxy-2-methylpropionic acids (5, 6), were prepared as analogues of the antiinflammatory arylpropionic acids of type B, in which the aromatic group is substituted by an MAOM moiety. Some of the new compounds. tested in vivo for their antiinflammatory properties by means of the carrageenan-induced paw edema method in rats, exhibited activity indices similar to that shown in the same test by ibuprofen. Compounds 3a.b and 4a,b, for which at least one of the two enantiomers had shown an inhibition value higher than 40% in the in vivo test, were assayed for their in vitro enzymatic inhibitory activity. showing percentage inhibition values between 40 and 50% at a concentration of 10 muM against COX-2: at the same concentration, they appeared to be devoid of any activity towards COX-1. Compounds 3a.b and 4a,b also proved to possess a similar toxicity. The lack of enantioselectivity shown by compounds 3-6 was tentatively explained in terms of a conformational freedom of the enantiomers which allows their quasi-superimposition. (C) 2001 Editions scientifiques et medicales Elsevier SAS.
引用
收藏
页码:799 / 808
页数:10
相关论文
共 24 条
  • [1] Structure of COX-1 and COX-2 enzymes and their interaction with inhibitors
    Bakhle, YS
    [J]. DRUGS OF TODAY, 1999, 35 (4-5): : 237 - 250
  • [2] USE OF (S)-(TRIFLOXYMETHYL)OXIRANE IN THE SYNTHESIS OF A CHIRAL BETA-ADRENOCEPTOR ANTAGONIST, (R) AND (S)-9-[[3-(TERT-BUTYLAMINO)-2-HYDROXYPROPYL]OXIMINO]FLUORENE
    BALDWIN, JJ
    MCCLURE, DE
    GROSS, DM
    WILLIAMS, M
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1982, 25 (08) : 931 - 936
  • [3] Structure-based design of COX-2 selectivity into flurbiprofen
    Bayly, CI
    Black, WC
    Léger, S
    Ouimet, N
    Ouellet, M
    Percival, MD
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (03) : 307 - 312
  • [4] NEW CHIRAL AND ISOMERIC CYCLOPROPYL KETOXIME PROPANOLAMINE DERIVATIVES WITH POTENT BETA-ADRENERGIC BLOCKING PROPERTIES
    BOUZOUBAA, M
    LECLERC, G
    RAKHIT, S
    ANDERMANN, G
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1985, 28 (07) : 896 - 900
  • [5] CHAN CC, 1995, J PHARMACOL EXP THER, V274, P1531
  • [6] Griswold DE, 1996, MED RES REV, V16, P181, DOI 10.1002/(SICI)1098-1128(199603)16:2<181::AID-MED3>3.0.CO
  • [7] 2-X
  • [8] INHIBITION OF CONSTITUTIVE AND INDUCIBLE CYCLOOXYGENASE ACTIVITY IN HUMAN PLATELETS AND MONONUCLEAR-CELLS BY NSAIDS AND COX-2 INHIBITORS
    GROSSMAN, CJ
    WISEMAN, J
    LUCAS, FS
    TREVETHICK, MA
    BIRCH, PJ
    [J]. INFLAMMATION RESEARCH, 1995, 44 (06) : 253 - 257
  • [9] JUBY PF, 1974, MED CHEM SERIES MONO, P92
  • [10] Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents
    Kurumbail, RG
    Stevens, AM
    Gierse, JK
    McDonald, JJ
    Stegeman, RA
    Pak, JY
    Gildehaus, D
    Miyashiro, JM
    Penning, TD
    Seibert, K
    Isakson, PC
    Stallings, WC
    [J]. NATURE, 1996, 384 (6610) : 644 - 648